Bank of New York Mellon Corp - LYRA THERAPEUTICS INC ownership

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,808
-25.7%
18,621
-4.5%
0.00%
Q3 2022$98,000
-43.7%
19,496
+29.7%
0.00%
Q1 2021$174,000
-21.6%
15,036
-22.7%
0.00%
Q4 2020$222,000
+26.9%
19,450
+24.3%
0.00%
Q3 2020$175,000
+15.9%
15,643
+18.1%
0.00%
Q2 2020$151,00013,2480.00%
Other shareholders
LYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 2,780,261$11,426,8732.01%
Nantahala Capital Management 3,957,542$16,265,4971.57%
Perceptive Advisors 12,757,562$52,433,5791.52%
PURA VIDA INVESTMENTS, LLC 1,413,242$5,717,7320.76%
Ikarian Capital, LLC 978,626$4,022,1530.64%
VR Adviser, LLC 924,170$3,798,3390.61%
Parkman Healthcare Partners LLC 600,000$2,466,0000.43%
DAFNA Capital Management LLC 361,084$1,484,0550.41%
Soleus Capital Management, L.P. 592,417$2,434,8340.27%
ARMISTICE CAPITAL, LLC 4,012,036$16,489,4680.24%
View complete list of LYRA THERAPEUTICS INC shareholders